The PSEN1 gene helps cells cut and recycle certain proteins, including one involved in brain health. This gene plays an important role in keeping protein processing balanced, and if it does not work properly, sticky amyloid pieces can build up in the brain. Certain inherited variants in the PSEN1 gene can cause familial early-onset Alzheimer’s disease, often with symptoms starting before age 65 and sometimes much earlier. PSEN1 is best known in medicine through families with inherited Alzheimer’s, rather than through celebrity stories.
What is a gene?
A gene is a stretch of DNA that holds instructions your cells use to make molecules or regulate processes in the body. Some genes provide the directions for building proteins, the parts of cells that do much of the work. Other genes mainly guide when, where, and how strongly certain processes happen. In combination, genes affect how the body develops and works, and they can also shape how you respond to food, stress, or medications. For a deeper look at this topic, you can find more in LearnHub.
Overview
PSEN1Gene function
What if the gene works
The PSEN1 gene helps cells cut certain proteins into usable pieces. This supports cell signaling, especially in the brain, and helps nerve cells work and communicate in a steady way.
Risk
What if the gene does not work
When the PSEN1 gene does not work properly, it can cause inherited early-onset Alzheimer disease, often before age 65. Milder and more severe variants can affect when symptoms begin and whether features like seizures or movement changes are also present.
Treatment
What does that mean for your treatment
No PSEN1-specific treatment or management approach is currently established. Care is generally based on standard Alzheimer disease treatment, not on a different drug choice because of the PSEN1 gene itself. The PSEN1 gene is widely studied in inherited Alzheimer disease, especially in trials of anti-amyloid and other disease-modifying treatments.
Conditions associated with PSEN1
Gene function
What if the gene works
Your cells rely on the PSEN1 gene to carry out careful protein cutting inside cell membranes. This supports routine cell communication and the normal handling of several membrane proteins, including APP. Understanding how the PSEN1 gene works helps you see how cells stay organized and responsive over time.
The PSEN1 gene provides a key part of a protein-cutting system called γ-secretase (an enzyme group that cuts proteins). This system trims selected proteins within the cell membrane so their messages can be passed along or their parts can be reused.
One of its main jobs is helping process Notch, a signal system that helps cells decide when to grow, mature, or take on a specific role. This supports coordinated cell communication during development and everyday tissue renewal.
The PSEN1 gene also helps process a protein called APP after other enzymes make the first cut. This is part of how the PSEN1 gene helps cells, including brain cells, manage membrane proteins in a steady, controlled way.
What is a variant?
A genetic variant is a minor change in a gene’s DNA sequence. These changes are common and help shape normal human differences, such as appearance, metabolism, or the way the body reacts to environmental influences. Many do not cause any noticeable effects and are simply part of natural genetic variation. Sometimes, though, a variant changes how a gene works more significantly and can contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
PSEN1 gene variants can change how the presenilin-1 protein folds and works within the cell’s protein-cutting complex, often shifting APP processing toward longer amyloid-beta fragments such as Aβ42. In plain terms, how PSEN1 gene variants affect protein function depends on the change: some mildly alter activity, while others more strongly disrupt protein stability or interactions. Variants with larger functional effects are often linked to earlier onset familial Alzheimer disease.
How variants are linked to conditions
Pathogenic variants in the PSEN1 gene are a well-established cause of inherited early-onset Alzheimer's disease, often called familial Alzheimer's disease. In affected families, a PSEN1 gene variant can confirm the diagnosis and is linked to symptoms that often begin before age 65, sometimes in the 30s to 50s. Some people also develop seizures, muscle stiffness, or walking problems as part of the condition.
A variant is not necessarily a diagnosis
Variants are a common and normal feature of human biology, and they occur widely across the general population. Most do not directly affect health and instead reflect natural human variation. For many genes, carrying a variant associated with a condition points to a possible link, not a certain diagnosis, particularly when several genes and environmental influences play a role. In other cases, one well-characterized variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For people with a disease-causing change in the PSEN1 gene, the chance of developing early-onset Alzheimer’s disease is largely set by the variant itself rather than by lifestyle or everyday exposures. Age is the main factor that changes when symptoms may begin, and there is not enough evidence to say that diet, exercise, or supplements lower this inherited risk.
Inheritance of PSEN1 variants
PSEN1-related Alzheimer disease is usually inherited in an autosomal dominant pattern. In practical terms, the inheritance of the PSEN1 gene variants means a parent carrying a disease-causing variant can pass it to a son or daughter, and each child has a 50% chance of inheriting that same variant. Men and women are affected and can pass it on equally. A small number of cases happen because of a new (de novo) variant, which means the change started in the affected person and was not inherited from either parent.
What does my PSEN1 result mean for my family?
A harmful change in the PSEN1 gene is usually linked to a dominantly inherited form of early-onset Alzheimer’s disease, so close relatives such as parents, brothers, sisters, and children may also carry the same change. In many families, each child of someone with the variant has a 1 in 2 chance of inheriting it. In some families, the change can be new in one person, so it does not always come from a parent.
Genetic information
Genetic testing
How you find out about variants
PSEN1 genetic testing for early-onset Alzheimer disease usually uses a blood or saliva sample to examine your DNA. It can show whether you carry a known pathogenic variant in the PSEN1 gene, whether a variant of uncertain significance (a change with unclear meaning) was found, or whether no relevant variant was detected.
When should I consider getting a genetic test?
Genetic testing for the PSEN1 gene may be worth considering if Alzheimer’s disease has affected several close relatives at a young age, often before age 65, or if someone develops memory and thinking problems unusually early. In these families, testing can help show whether an inherited PSEN1 change is involved.
A genetic result is only one part of your health story
Genetic results can provide useful insight, but how much they reveal depends on the condition and on the kind of variant involved. Many other factors, including lifestyle, environment, age, and medical history, also shape how the body works over time. In some conditions, especially those influenced by many genes, genetic information offers context rather than certainty and is most useful when viewed alongside other parts of care. In other situations, a genetic result can give a clear answer. In areas such as medication response, genetic findings can also help make individual experiences easier to understand.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in DNA can change how the body breaks down a drug, moves it through the body, or responds to it at its target. This helps explain why the same treatment works well for one person, seems less effective for another, or causes more side effects in someone else.
What is Pharmacogenetics?
Pharmacogenetics looks at how differences in a person’s genes can shape their response to medicines. It studies connections between genes and drugs to help explain why the same treatment may work differently from one person to another. For many medications, genes influence both how strong a drug’s effects are and how the body handles it. This information can support treatment decisions that are more informed and more individualized. You can read more about this topic in the LearnHub.
Drugs influenced by the PSEN1 gene
When should I seek medical advice?
There isn’t yet a broadly confirmed role for this gene in guiding medication choice or dose, so general questions about symptoms, treatment, or side effects are best discussed with your doctor.
History
The PSEN1 gene entered medical history in the mid 1990s, when researchers studying families with inherited early-onset Alzheimer’s disease traced the cause to chromosome 14. In 1995, this work led to identification of the PSEN1 gene as a major cause of some familial cases that begin unusually early in adult life. Initially understood only through visible traits, later recognized as tied to a specific gene, these family patterns helped confirm that Alzheimer’s can sometimes have a strong inherited form. The discovery marked a turning point for dementia research and made genetic testing more informative for certain families. From these first observations, research expanded steadily. PSEN1 remains one of the best known genes linked to inherited early-onset Alzheimer’s disease.